- Africa’s cement industry and the push for energy security - Krzysztof Lokaj, Wärtsilä Energy Africa Development Manager
- The 2026 Budget doubled your single discretionary allowance - Harry Scherzer, CEO, Future Forex
- Exclusive Convo: Nafissatou Fall Diagne, Managing Director, Development Finance Advisory
- Exclusive Interview: Sotiguy Coulibaly, Chief Executive Officer, KERALES FINANCE
- British International Investment targets £9 billion of new capital for Africa
French Drugs Maker Targets Africa With Nigerian Acquisition
LAGOS (Capital Markets in Africa) – Biogaran SAS, a closely held French pharmaceuticals manufacturer, plans to tap into Nigeria’s $1.3 billion drugs market as a launchpad for its expansion into Africa, company President Pascal Briere said. The unit of France’s second-largest drug maker, Les Laboratoires Servier, last month acquired Nigeria’s Swipha Limited. after an initial $500,000 investment. Biogaran expects Nigeria’s pharmaceuticals industry to grow by more than 12 percent annually. “We found that Nigeria is well adapted for what we…
Read More


